[Thrombin: antithrombotic properties and pharmacological consequences].

Area of Science:

• Vascular biology
• Hemostasis and thrombosis
• Endothelial cell function

Context:

• Endothelial cell cultures have advanced understanding of circulatory system mechanisms.
• Thrombin is a central enzyme in hemostasis, catalyzing fibrin formation and platelet aggregation.
• Endothelial cells express binding sites for coagulation factors and von Willebrand protein upon stimulation.

Purpose:

• To elucidate the dual role of thrombin in thrombosis and antithrombosis.
• To detail the mechanisms by which healthy endothelium regulates thrombin's effects.
• To evaluate hemostatic risk factors and inform new antithrombotic strategies.

Summary:

• Thrombin, a serine protease, is crucial for hemostasis, promoting fibrin formation and platelet aggregation.
• Paradoxically, low thrombin concentrations with intact endothelium inhibit thrombosis via specific antithrombotic pathways.
• These pathways include thrombin-induced autacoid formation, protein C activation, and cofactor absorption.

Impact:

• Provides a deeper understanding of complex pro- and antithrombotic mechanisms.
• Enables critical evaluation of established hemostatic risk factors.
• Facilitates the development of novel pharmacologic strategies for thrombosis prevention.